MEGA Stock Overview
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Mega Lifesciences Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿46.25 |
| 52 Week High | ฿52.50 |
| 52 Week Low | ฿34.75 |
| Beta | 0.47 |
| 1 Month Change | 9.47% |
| 3 Month Change | 27.59% |
| 1 Year Change | -2.12% |
| 3 Year Change | 27.59% |
| 5 Year Change | 20.13% |
| Change since IPO | 117.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEGA | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | 5.1% | -1.9% | -1.2% |
| 1Y | -2.1% | 12.0% | -6.7% |
Return vs Industry: MEGA underperformed the TH Pharmaceuticals industry which returned 12% over the past year.
Return vs Market: MEGA exceeded the TH Market which returned -6.7% over the past year.
Price Volatility
| MEGA volatility | |
|---|---|
| MEGA Average Weekly Movement | 3.4% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in TH Market | 8.6% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: MEGA is not significantly more volatile than the rest of TH stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: MEGA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | Vivek Dhawan | https://www.megawecare.com |
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It provides various medicines for allergy, blood circulation and memory, bone and joint, kids, liver and digestive, eye, heart, pain, skin, sleeping, well-being, herbal, and cough and cold care, as well as vitamins, probiotics, medical and sports nutrition, and men’s and women’s care products; and prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardio vascular system, dermatology, diabetes, gastroenterology, gynaecology, nephrology, oncology, ophthalmology, orthopaedic, pain, respiratory, rheumatology, and urology.
Mega Lifesciences Public Company Limited Fundamentals Summary
| MEGA fundamental statistics | |
|---|---|
| Market Cap | ฿40.32b |
| Earnings (TTM) | ฿2.04b |
| Revenue (TTM) | ฿15.69b |
19.7x
P/E Ratio2.6x
P/S RatioIs MEGA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEGA income statement (TTM) | |
|---|---|
| Revenue | ฿15.69b |
| Cost of Revenue | ฿8.55b |
| Gross Profit | ฿7.14b |
| Other Expenses | ฿5.10b |
| Earnings | ฿2.04b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 14, 2023
| Earnings per share (EPS) | 2.34 |
| Gross Margin | 45.51% |
| Net Profit Margin | 13.01% |
| Debt/Equity Ratio | 3.0% |
How did MEGA perform over the long term?
See historical performance and comparison